|
C10ORF46 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.628400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.947000E-01 |
| Normal-vs-Stage2 |
4.649800E-01 |
| Normal-vs-Stage3 |
4.826200E-01 |
| Normal-vs-Stage4 |
7.014800E-01 |
| Stage1-vs-Stage2 |
1.457630E-01 |
| Stage1-vs-Stage3 |
9.001400E-01 |
| Stage1-vs-Stage4 |
7.556400E-01 |
| Stage2-vs-Stage3 |
1.673640E-01 |
| Stage2-vs-Stage4 |
2.740200E-01 |
| Stage3-vs-Stage4 |
7.182200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.477600E-01 |
| Normal-vs-AfricanAmerican |
2.072300E-02 |
| Normal-vs-Asian |
5.169600E-01 |
| Caucasian-vs-AfricanAmerican |
7.620500E-02 |
| Caucasian-vs-Asian |
7.887700E-02 |
| AfricanAmerican-vs-Asian |
3.303400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.940800E-01 |
| Normal-vs-Female |
5.714200E-01 |
| Male-vs-Female |
9.573000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.105800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.285800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.018200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.014000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.812000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.085800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.419000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.984200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.580800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.887200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.589600E-01 |
| Classical-VS-Follicular |
2.33579999997513E-06 |
| Classical-VS-Other |
3.044200E-01 |
| Classical-VS-Normal |
9.811700E-02 |
| Tall-VS-Follicular |
5.260200E-03 |
| Tall-VS-Other |
3.203600E-01 |
| Tall-VS-Normal |
1.727220E-01 |
| Follicular-VS-Other |
6.278200E-01 |
| Follicular-VS-Normal |
7.420000E-02 |
| Other-VS-Normal |
7.295200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.891200E-01 |
| Normal-vs-N1 |
6.030400E-01 |
| N0-vs-N1 |
7.529200E-01 |
|
|
